Skip to content
Back to Guavy Wire
Stocks

Taylor Buys Amgen, Sells Marathon as His Investment Portfolio Sees Action

Instruments
AMGN HD
Share

Representative David J. Taylor of Ohio's 2nd congressional district has made significant transactions in his investment portfolio, according to a recent congressional trade report.

The transactions include buying common stock in biopharmaceutical company Amgen Inc. and home improvement retailer Home Depot, Inc., both valued between $1,001 and $15,000. The purchases were made on September 22, 2026, through different accounts under the David Taylor Trust, including the Sardinia Ready Mix 401(k) - Dave and the Schwab Joint Brokerage #1 (Home Grown).

Amgen shares currently trade at $402.97 with a market cap of $220.18 billion and have delivered strong returns of 39% over the past year, according to InvestingPro analysis. The biotech giant has raised its dividend for 15 consecutive years.

More on Stocks

Disclaimer: Guavy is a data and market intelligence provider, not an investment adviser. The information, signals, and market analysis provided by the Guavy API and related services are for informational purposes only and are not intended as financial advice, investment recommendations, or an endorsement of any particular trading strategy. Trading in volatile markets, including cryptocurrency, carries significant risk and may not be suitable for all investors. Past performance is not indicative of future results. Users should consult with a qualified financial professional before making any investment decisions. Guavy makes no guarantee of trading profits or financial returns.

Market sentiment intelligence for apps, funds & agents

Location

729 55 Ave SW
Calgary AB T2V 0G4
Canada

© 2026 Guavy Inc